vs

Side-by-side financial comparison of CHINA PHARMA HOLDINGS, INC. (CPHI) and Professional Diversity Network, Inc. (IPDN). Click either name above to swap in a different company.

Professional Diversity Network, Inc. is the larger business by last-quarter revenue ($1.7M vs $1.2M, roughly 1.4× CHINA PHARMA HOLDINGS, INC.). CHINA PHARMA HOLDINGS, INC. runs the higher net margin — -99.7% vs -173.5%, a 73.8% gap on every dollar of revenue. On growth, CHINA PHARMA HOLDINGS, INC. posted the faster year-over-year revenue change (8.1% vs 3.1%). Professional Diversity Network, Inc. produced more free cash flow last quarter ($1.4M vs $151.5K). Over the past eight quarters, Professional Diversity Network, Inc.'s revenue compounded faster (-1.7% CAGR vs -5.4%).

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

CPHI vs IPDN — Head-to-Head

Bigger by revenue
IPDN
IPDN
1.4× larger
IPDN
$1.7M
$1.2M
CPHI
Growing faster (revenue YoY)
CPHI
CPHI
+5.0% gap
CPHI
8.1%
3.1%
IPDN
Higher net margin
CPHI
CPHI
73.8% more per $
CPHI
-99.7%
-173.5%
IPDN
More free cash flow
IPDN
IPDN
$1.3M more FCF
IPDN
$1.4M
$151.5K
CPHI
Faster 2-yr revenue CAGR
IPDN
IPDN
Annualised
IPDN
-1.7%
-5.4%
CPHI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPHI
CPHI
IPDN
IPDN
Revenue
$1.2M
$1.7M
Net Profit
$-1.2M
$-2.9M
Gross Margin
12.3%
33.7%
Operating Margin
-97.9%
-173.2%
Net Margin
-99.7%
-173.5%
Revenue YoY
8.1%
3.1%
Net Profit YoY
0.2%
-280.0%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPHI
CPHI
IPDN
IPDN
Q4 25
$1.2M
$1.7M
Q3 25
$756.2K
$1.7M
Q2 25
$1.0M
$1.6M
Q1 25
$1.1M
$1.5M
Q4 24
$1.1M
$1.6M
Q3 24
$1.1M
$1.7M
Q2 24
$924.9K
$1.7M
Q1 24
$1.4M
$1.7M
Net Profit
CPHI
CPHI
IPDN
IPDN
Q4 25
$-1.2M
$-2.9M
Q3 25
$-651.5K
$-2.4M
Q2 25
$-528.4K
$-476.0K
Q1 25
$-785.6K
$-722.1K
Q4 24
$-1.2M
$-761.9K
Q3 24
$-1.1M
$-405.0K
Q2 24
$-1.4M
$-553.1K
Q1 24
$-955.9K
$-791.8K
Gross Margin
CPHI
CPHI
IPDN
IPDN
Q4 25
12.3%
33.7%
Q3 25
-7.9%
44.0%
Q2 25
-8.5%
43.4%
Q1 25
-12.0%
52.2%
Q4 24
-14.2%
58.6%
Q3 24
-47.2%
58.9%
Q2 24
-109.8%
62.9%
Q1 24
-21.2%
62.2%
Operating Margin
CPHI
CPHI
IPDN
IPDN
Q4 25
-97.9%
-173.2%
Q3 25
-83.1%
-136.3%
Q2 25
-63.6%
-30.2%
Q1 25
-66.8%
-46.9%
Q4 24
-105.5%
-36.8%
Q3 24
-98.6%
-25.0%
Q2 24
-150.4%
-34.4%
Q1 24
-66.9%
-46.5%
Net Margin
CPHI
CPHI
IPDN
IPDN
Q4 25
-99.7%
-173.5%
Q3 25
-86.2%
-136.2%
Q2 25
-51.5%
-29.0%
Q1 25
-69.1%
-48.0%
Q4 24
-108.0%
-47.1%
Q3 24
-101.6%
-23.9%
Q2 24
-155.5%
-32.7%
Q1 24
-69.8%
-45.9%
EPS (diluted)
CPHI
CPHI
IPDN
IPDN
Q4 25
$-0.17
Q3 25
$-0.17
Q2 25
$-0.16
Q1 25
$-0.24
Q4 24
$-0.45
Q3 24
$-0.65
Q2 24
$-0.89
Q1 24
$-0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPHI
CPHI
IPDN
IPDN
Cash + ST InvestmentsLiquidity on hand
$345.1K
$217.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$22.7M
$11.7M
Total Assets
$31.0M
$17.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPHI
CPHI
IPDN
IPDN
Q4 25
$345.1K
$217.0K
Q3 25
$267.6K
$265.3K
Q2 25
$600.0K
$125.1K
Q1 25
$400.0K
$496.4K
Q4 24
$626.9K
$1.7M
Q3 24
$700.0K
$133.7K
Q2 24
$619.3K
Q1 24
$97.1K
Stockholders' Equity
CPHI
CPHI
IPDN
IPDN
Q4 25
$22.7M
$11.7M
Q3 25
$8.3M
$8.9M
Q2 25
$6.5M
$4.5M
Q1 25
$7.0M
$4.9M
Q4 24
$7.7M
$5.3M
Q3 24
$6.5M
$2.1M
Q2 24
$7.4M
$2.5M
Q1 24
$8.3M
$2.3M
Total Assets
CPHI
CPHI
IPDN
IPDN
Q4 25
$31.0M
$17.9M
Q3 25
$15.8M
$12.1M
Q2 25
$13.8M
$7.3M
Q1 25
$14.2M
$7.7M
Q4 24
$14.9M
$8.0M
Q3 24
$13.5M
$5.3M
Q2 24
$14.3M
$5.8M
Q1 24
$5.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPHI
CPHI
IPDN
IPDN
Operating Cash FlowLast quarter
$152.0K
$1.4M
Free Cash FlowOCF − Capex
$151.5K
$1.4M
FCF MarginFCF / Revenue
12.4%
84.4%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$88.8K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPHI
CPHI
IPDN
IPDN
Q4 25
$152.0K
$1.4M
Q3 25
$-237.0K
$-2.7M
Q2 25
$291.1K
$-495.5K
Q1 25
$-57.8K
$-284.1K
Q4 24
$298.8K
$-1.2M
Q3 24
$-47.0K
$-556.9K
Q2 24
$-72.7K
$-224.4K
Q1 24
$-585.2K
$-543.1K
Free Cash Flow
CPHI
CPHI
IPDN
IPDN
Q4 25
$151.5K
$1.4M
Q3 25
$-237.6K
$-2.7M
Q2 25
$291.0K
$-499.5K
Q1 25
$-116.1K
Q4 24
$-1.2M
Q3 24
$-56.2K
$-558.9K
Q2 24
$-225.9K
Q1 24
$-543.6K
FCF Margin
CPHI
CPHI
IPDN
IPDN
Q4 25
12.4%
84.4%
Q3 25
-31.4%
-156.8%
Q2 25
28.4%
-30.4%
Q1 25
-10.2%
Q4 24
-74.0%
Q3 24
-5.1%
-33.0%
Q2 24
-13.4%
Q1 24
-31.5%
Capex Intensity
CPHI
CPHI
IPDN
IPDN
Q4 25
0.0%
0.0%
Q3 25
0.1%
0.0%
Q2 25
0.0%
0.2%
Q1 25
5.1%
0.0%
Q4 24
1.3%
Q3 24
0.8%
0.1%
Q2 24
0.1%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons